Ted Cohen: Travelling for TB

By Amy Maxmen Ted Cohen: Travelling for TB Porter Gifford Assistant professor, Department of Epidemiology, Harvard School of Public Health. Age: 37 From as early as he can remember, Ted Cohen wanted to address tangible problems. Armed with a medical degree from Duke and an MPH from the University of North Carolina, he headed north to pursue a doctorate in public health. His Harvard School of Public Health mentor, Megan Murray, introduced him to the study

Written byAmy Maxmen
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Assistant professor, Department of Epidemiology, Harvard School of Public Health. Age: 37

From as early as he can remember, Ted Cohen wanted to address tangible problems. Armed with a medical degree from Duke and an MPH from the University of North Carolina, he headed north to pursue a doctorate in public health. His Harvard School of Public Health mentor, Megan Murray, introduced him to the study of tuberculosis (TB), a devastating disease that has challenged research and eradication efforts for more than a century.

According to the World Health Organization (WHO), 1.8 million people died of TB in 2008—nearly 5,000 people per day. And antibiotic-resistant strains of the TB bacterium, which cost as much as 200 times more to treat, appear to be on the rise, especially in the developing world. Cohen focuses on strategies to banish these intractable cases of TB, and his research takes him around the world.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies